Testosterone therapy – Memphis Trial Attorneys

February 6, 2014

Testosterone Therapy Increases Odds of Stroke by Thirty Percent (30%)

FREE CASE EVALUATION: CALL 1-800-632-1404

Wrong Low T Therapy Treatment Widespread, Users at 30 Percent Higher Risk of Heart Attack

Two recent studies have highlighted that the use of inappropriate testosterone therapy among U.S. men puts them at a greater risk of cardiovascular diseases, including heart attack. According to the Journal of Clinical Endocrinology & Metabolism, while the number of testosterone therapy users has registered a five-fold rise in the United States, only a small percentage of them adhere to appropriate testing and user guidelines. Published in January 2014, the report highlights that a vast majority of them are receiving the Low T supplements without any test or even after have been tested with normal testosterone levels.

Researchers hold that aggressive and direct-to-consumer marketing by manufacturers of testosterone supplements, such as AndroGel, Androderm, Testim, and others, was responsible for large-scale inappropriate use by men. Advertisements focus on encouraging men to go for Low T medications to increase their muscles, sexual ability, and energy level. Hypogonadism or testosterone deficiency, for which the supplements are available, is no more a condition for the treatment.

The study found that the abuse was more prevalent in the United States despite a severe risk of testosterone therapy cardiovascular side effects. The enthusiasm to increase libido and strength pushes them to “initiate the testosterone therapy at normal levels and many even initiate it without recent testing,” researchers claim.

30 Percent Increase in Fatal Heart Attack Risk

Testosterone therapy may cause serious and fatal cardiovascular side effects. The testosterone therapy heart attack risk leading to stroke and death is as high as 30 percent when compared to those not using Low T supplements, the Journal of the American Medical Association reported in November 2013. Based on a study of ex-servicemen registered with the Eastern Colorado Health Care System, it found nearly 30 percent greater risk of serious and fatal heart problems linked to testosterone therapy. We expect that scientists will continue to link Low T therapy with cardiovascular injuries.

According to the JAMA report, Low T supplements play a role in increasing cardiovascular disorders risk of heart attack, stroke, and death. Of 8,700 men with low level of testosterone and coronary angiography studied, 1,223 received supplements to boost their testosterone production. Doctors discovered that 26 percent of those treated with the Low T supplements had suffered a stroke or heart attack, with a few deaths, within three years. The rate of same events among the non-testosterone group was less than 20 percent. It was found that those treated with testosterone therapy faced a higher risk of cardiovascular disorder despite being younger and with very few health disorders.

FDA Advises Against “Age-Related” Testosterone Therapy Solution

According to the FDA guidelines, men should not use testosterone therapy to prevent normal reduction in hormone production with age. Low T solutions are only for those suffering from hypogonadism, a medical conditions that results in testosterone deficiency. The Endocrine Society has also advised against use of testosterone supplements without proper clinical diagnosis and abnormal reduction in testosterone levels. The fatal side effects of Low T supplements play a crucial role in the publication of such suggestions. We recommend you, of course, consult with your doctor about whether to undergo a Low T program.

However, contrary to all these warnings, manufacturers continue to promote the Low T supplements through direct-to-consumer ads, a key factor in men using testosterone therapy on their own and facing fatal side effects.

If you or a loved one have experienced a testosterone replacement therapy injury after undergoing low testosterone therapy, please contact our team of lawyers today for a free case evaluation at:

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming

February 6, 2014

Testosterone Therapy Health Risk Eclipses Benefits

FREE CASE EVALUATION: CALL 1-800-632-1404

Testosterone Therapy: Health Risks Eclipse Benefits

With mounting evidence suggesting serious health risks connected to testosterone therapy, doctors healthcare professionals have become cautious in suggesting Low T supplements to patients. Testosterone therapy use has almost quintupled in the last 11 years with over 5.5 million prescriptions and $2 billion in supplement sales. However, there is an increased risk of health disorders from the therapy. Recent studies have indicated that the use of Low T supplements without clinical diagnosis of testosterone deficiency may result in heart attack, stroke, or cardiovascular adverse events leading to death.

Post-marketing reports suggest higher prostate-specific antigens, a leading cause of prostate cancer, among testosterone therapy patients. Abnormal increase in blood counts, clots, metabolic disorders, and a variety other health problems may cause Low T users to suffer more than they gain.

According to Mayo Clinic experts, testosterone also leads to male breast abnormalities, dermatological disorders, and sleep apnea, which may worsen quality of life.

Testosterone Therapy Side Effects

Wrongful Death: Low T supplements result in the onset and aggravation of existing heart disorders, which may cause testosterone death.
Cardiovascular Disorders: Testosterone therapy may cause 30 percent greater risk of cardiovascular problems. Heart attack and stroke are most reported disorders connected to the treatment.
Blood Clots: Low T supplements have been linked to the heightened risk of clotting within arteries. It leads to thrombotic events that prevent blood circulation to heart, brain, and lungs.
Metabolic and Sleep Disorders: Reversing age-specific testosterone formation results in metabolic syndrome, sleep apnea, rise in cholesterol level, and diabetes, impacting the life quality of users.
Prostate Cancer: Researchers have discovered an increase in prostate-specific antigens caused by Low T supplements. It may result in prostate cancer.
Endocrine Disparity
Worsening kidney and liver problems

FDA on Testosterone Therapy

Testosterone supplements are recommended for medical conditions, such as hypogonadism. The manufacturer claims that these help prevent natural decline in the hormone level caused by age-related factors. The federal regulator also advises for adequate clinical testing prior to using Low T supplements to boost testosterone production. A boxed warning mandated by the FDA for AndroGel and Testim, two Low T supplements commonly used by people to stay young and improve health, cautions users against secondary exposure that may cause children and women to have fast and unusual psychological and sexual behavioral changes.

Testosterone Therapy Lawsuits

The recent researches highlighting heart disorders and death due to Low T supplements have resulted in a number of testosterone therapy lawsuits. A recent Wall Street Journal report, claiming an abrupt end of a testosterone trial by the National Institutes of Health in 2009 because of high rate of cardiovascular problems in patients, have added further support to the allegations by litigants.

Anyone who has suffered from injuries following the use of Low T supplements can file a testosterone therapy lawsuit seeking product liability against the medication manufacturer. Contact an experienced drug injury attorney to evaluate your claim.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 29, 2014

CBS Reports Testosterone Therapy Can Cause Heart Attack, Stroke and Death

FREE CASE EVALUATION: CALL 1-800-632-1404

httpv://www.youtube.com/watch?v=kogkW1lil5s

Dr. Jon Lapook of CBS News reviewed the recent JAMA article showing a 29% increased risk for men over 60 undergoing testosterone replacement therapy and suffering from a blood clot, stroke or other similar attack. The video likewise contains the comments of Dr. Steve Missen of the Cleveland Clinic and Dr. Elizabeth Kavalere, a urologist.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 29, 2014

What Were the Results of the JAMA Study on Testosterone Replacement Therapy?

FREE CASE EVALUATION: CALL 1-800-632-1404

What Were the Results of the JAMA Study on Testosterone Replacement Therapy?

The JAMA study looked at two groups of veterans with medical problems in the VA Health System, including (1) those who were taking testosterone therapy to treat low testosterone and (2) those who were not. The group of veterans taking testosterone therapy were generally healthier than the veterans who were not taking testosterone therapy. The study found that in a three year period the men on testosterone therapy suffered 29% more heart attacks, strokes and deaths than the men who were not on testosterone therapy. The study’s authors ruled out other diseases as a cause of this association.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 29, 2014

Are Patients Being Injured With Testosterone Therapy While Companies Make Millions in Profits?

FREE CASE EVALUATION: CALL 1-800-632-1404

You may be visiting this website because you or a loved one has experienced a testosterone replacement injury including a testosterone stroke, a testosterone heart attack or a testosterone blood clot. If so, please keep reading.

In the opinion of some, large businesses have turned testosterone-boosting drugs into a $2 billion marke. In a new study in the Journal of the American Medical Association there are concerns over Low T therapy: it may cause cardiovascular events such as heart attacks, blood clots, strokes and pulmonary embolism. These would result in a low testosterone injury.

Over the past couple of years, therapies such as Eli Lilly’s Axiron; AbbVie’s AndroGel; and Auxilium and GlaxoSmithKline’s Testim have taken off like a rocket as companies rolled out new products and amped up their advertising. IMS Health says sales of testosterone drugs grew by 90% over 5 years, reaching $1.9 billion in 2011. By 2017, the entire testosterone market is expected to hit $5 billion.

Researchers analyzed the medical records of 8,709 male veterans with low testosterone who had a coronary angiogram. Of that group, 1,223 men began testosterone therapy after their procedure. The rate of death, heart attack or stroke hit 25.7% in that group, compared with 19.9% in the men who didn’t use testosterone drugs

After controlling for various factors, the researchers calculated a 29% increase in risk for the men who used testosterone. And as Forbes points out, the change in risk was the same in men who had coronary artery disease as in men who didn’t–and the testosterone group had a lower risk profile to begin with. The research isn’t conclusive; as an observational study, it’s more of a flag for future study than a clear warning. A JAMA editorial points out that the analysis includes little information about whether the drugs were prescribed according to label guidelines. But the editorial also advises caution. The number of prescriptions is growing quickly, and drugmakers continue to aggressively advertise the treatments. As the editorial points out, some men are using testosterone for lifestyle reasons, rather than to replace actual, clinical deficits in their hormone levels–for antiaging and “physical enhancement,” for instance, JAMA notes. Does any increase in risk apply to these younger, perhaps healthier, men?

Here’s where pharma advertising comes in. Earlier this year, Consumer Reports urged men to be wary about starting hormone therapy, saying most men really don’t need the drugs. The magazine cited drugmakers’ big-time spending on marketing the products, with promotional expenses up to $100 million in 2012 from $14 million in 2011. For 2013, that figure may grow substantially. For the first half of this year alone, AbbVie spent more than $45 million promoting Androgel, which is now its second-best-selling drug. Still, AbbVie, Lilly and other drugmakers say they only market their testosterone products for men whose hormone levels are clinically low. For now, the data on testosterone use is far from comprehensive. A National Institutes of Health study is set to wrap up next year. In the meantime, the JAMA researchers say their study at least offers some perspective. “Prior to this study, we didn’t know much about the cardiovascular risk,” said lead author Michael Ho, a cardiologist with the Veterans Affairs Eastern Colorado Health Care System.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 27, 2014

Increased Cardiovascular Risk in Men Using Testosterone Therapy Prompts Concern to General Public

FREE CASE EVALUATION: CALL 1-800-632-1404

Men May Suffer From a Stroke, Blood Clot or Heart Attack After Undergoing Testosterone Replacement Therapy Says University of Pennsylvania

According to the University of Pennsylvania Health System, men taking testosterone therapy had a 29 percent greater risk of death, heart attack and stroke according to a study of a “real world” population of men. An accompanying editorial in JAMA by an endocrinologist with the Perelman School of Medicine at the University of Pennsylvania notes that the mounting evidence of a signal of cardiovascular risk warrants cautious testosterone prescribing and additional investigation. In our opinion, these two points add up to one conclusion: there may certainly be an increased risk of cardiovascular injury with the ingestion of testosterone replacement therapy. Indeed, an estimated 2.9 percent of men over 40 years old in the United States are prescribed testosterone therapy, yet there are limited randomized trial data examining the long term benefits and risks. One CBS news study pointed out that there were 400 million prescriptions for testosterone replacement therapy in 2012 alone.

In the JAMA study reference above, patients in the VA system compared 1,223 men taking testosterone with 7,489 men not using testosterone and found a greater percentage of deaths, heart attacks, blood clots, pulmonary embolism and strokes in the testosterone group. Approximately 1 in 5 men not taking the therapy had such an event, whereas more than 1 in 4 men taking testosterone had a heart attack, stroke, or died over a three year period.

“We do not know if this risk extends to men who are taking testosterone for ‘low T syndrome’ or younger men taking it for physical enhancement, as there is a lack of long term safety data of testosterone therapy in men,” said Anne Cappola, MD, ScM, associate professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism in the Perelman School of Medicine at the University of Pennsylvania. “But the men who were taking testosterone in this study were slightly healthier to begin with, and surprisingly had a higher risk of catastrophic events.”

Dr. Cappola notes that additional information from the ongoing T Trial – a randomized trial of 800 men aged 65 and older with diminished walking ability, interest in sex, energy, memory or iron levels in blood who will receive testosterone gel or placebo for one year – may provide important guidance to older men who meet current recommendations for testosterone therapy. Until then, Dr. Cappola notes that “prescribers and patients should be wary.”

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 27, 2014

What are the Long Term Risks of Testosterone Replacement Therapy?

FREE CASE EVALUATION: CALL 1-800-632-1404

What are the Long Term Risks of Testosterone Replacement Therapy?

There is no certain answer to this question according to academic papers and peer reviewed articles. Physicians currently admit via the Journal of the American Medical Association that the long term side effects associated with the use of testosterone replacement therapy and testosterone supplements were not well known. Doctors, including the authors of the JAMA study, have now taken the position that further research, including randomized clinical trials, are needed to further characterize the risks associated with testosterone therapy to treat low testosterone.

As we have pointed out on our website, one JAMA study has linked testosterone replacement therapy with a 29% increase in risk for a cardiovascular event, such as a heart attack, stroke, blood clot, pulmonary embolism or death. Our firm is currently providing free case evaluations to persons who want to file a testosterone replacement therapy lawsuit.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 27, 2014

What Types of Testosterone Medication Could Cause A Blood Clot, Stroke or Heart Attack?

FREE CASE EVALUATION: CALL 1-800-632-1404

What Types of Testosterone Medication Could Cause A Blood Clot, Stroke or Heart Attack?

Testosterone can be administered in several different ways and by several different manufactures. Each of these types of testosterone replacement therapies are suspected to cause a 29% increase in the risk of heart attack, stroke and death.

Testosterone Gels and Creams

AndroGel is a gel testosterone medication that is applied to the shoulder or upper arms daily.
Axiron is a testosterone medication that is applied to the underarm area daily.
Fortesta is a gel testosterone medication that is applied to the thighs daily.
Testim is a gel testosterone medication that is applied to the shoulders daily.

Testosterone Injections

Delatestryl is a testosterone injection.

Other Types of Testosterone Drugs

Androderm is a testosterone patch that is applied to the stomach, thighs, back or upper arms daily.
Striant is a testosterone medication that adheres to the gums and is placed twice daily.
Testopel is a pellet testosterone medication that is placed under the skin to continuously deliver testosterone for 3 – 6 months at a time.

Recent research indicates that any of these types of testosterone replacement therapy can cause a 29% increase in the risk of heart attack, stroke and death.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 27, 2014

Who is Sued in a Testosterone Therapy Injury Lawsuit?

FREE CASE EVALUATION: CALL 1-800-632-1404

Who is Sued in a Testosterone Therapy Injury Lawsuit?

In most instances, several entities may be sued for a testosterone related injury including the manufacturer of the testosterone related therapy, the developer of the testosterone drug, or the distributor of the testosterone medicine. Your team of testosterone attorneys will not at this point in time sue any doctor related to your Low T therapy.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

January 27, 2014

Do You Charge an Initial Case Evaluation Fee for a Testosterone Therapy Related Stroke, Blood Clot or Heart Attack?

FREE CASE EVALUATION: CALL 1-800-632-1404

Do You Charge an Initial Case Evaluation Fee for a Testosterone Therapy Related Stroke, Blood Clot or Heart Attack?

We do not charge anything for an initial case evaluation. In fact, we handle testosterone replacement therapy lawsuits on a contingency fee basis meaning we do not charge a fee unless there is a recovery for you or your loved one. That means that if there is a judgment at trial for a testosterone injury, we would receive a portion of the fee as our fee. If you do not prevail in your testosterone therapy lawsuit, we would be owed nothing on the fee.

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?